News

NDTV Profit on MSN15h
Birlasoft Gets Antique Stock Broking's 'Hold' Initiation As Gradual Turnaround Seen — Check Target Price
Antique Stock Broking has initiated coverage on Birlasoft, an IT services provider, with a 'hold' rating and a target price of Rs 450, suggesting a potential upside of 4% on the counter. The brokerage ...
ABP News on MSN7h
Cross-Border Payment DeGays Cost Indian Businesses Millions: Zil Money's Technology Delivers Payments In Minutes
Zil Money's blockchain-powered platform enables Indian businesses to receive US payments in minutes instead of 5-7 days, ...
NSE-SME Stock Launches QIP, Sets Floor Price At Rs 268.85 Per Share
One of the leading creative visual effects (VFX) companies in the industry, Phantom Digital Effects Limited (NSE: PHANTOMFX), ...
The Manila Times5h
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
Werewolf Therapeutics, Inc. (the 'Company” or 'Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...
Nomura predicts 18% downside in Godrej Properties, sees Phoenix Mills falling 11% on lofty valuations
Nomura initiates 'reduce' ratings on Godrej Properties and Phoenix Mills. The brokerage projects an 18% downside for Godrej ...
Solid Biosciences Inc.: Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic ...
SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Design ...
Solid Biosciences Announces FDA IND And Health Canada CTA Approval For First-In-Class Cardiac Gene Therapy To Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has rec ...